Guide: WHO guidelines on Good Participatory Practice for Trials of Emerging Pathogens (GPP-EP)by Mesh Editorial Team, Dr Catherine Hankins
GPP-EP were prepared in 2016 by the WHO to support prevention and treatment trials of emerging (and re-emerging) pathogens that were likely to cause severe outbreaks. The guidelines address how to engage community stakeholders and promote ethical standards throughout the research process.
Published Report: Research in global health emergenciesby Mesh Editorial Team, Nuffield Council on Bioethics
This Nuffield Council on Bioethics report from January 2020 contains the findings of a two year in-depth inquiry. The aim was to identify ways in which research can be undertaken ethically during emergencies, in order to promote the contribution that ethically-conducted research can make to improving current and future emergency preparedness and response.
This article addresses community engagement around the COVID-19 outbreak in South Africa in April 2020 and proposes a free-to-use mobile app as well as a longer-term Community Engagement Nerve Centre for the country
Literature: The Communication and Community Engagement Response to Ebola, 2014-2015: Evidence and Lessons for Future Global Health Crisesby Mesh Editorial Team, D. Nabarro et al, 2017
Report: Ebola Strategic Frameworkby International Red Cross and Red Crescent Movement, Mesh Editorial Team
Literature: Building the legacy of Ebola: Survivors, health systems and a blueprint for research and developmentby The WHO, Mesh Editorial Team
Academic Literature: Word of Mouth: Learning from Polio Communication and Community Engagement Initiatives - Insights and Ideas to Accelerate Action on Other Development Issuesby USAID Maternal Child Survival Program, Mesh Editorial Team
Video: ISNTD: Sustaining Vaccines Confidence in a Post-truth Era - panel discussion highlightsby Mesh Editorial Team
Academic Literature: Conventional Wisdom versus Actual Outcomes: Challenges in the Conduct of an Ebola Vaccine Trial in Liberia during the International Public Health Emergencyby Larson et al 2017, Mesh Editorial Team
This paper is an assessment of a phase II, randomized controlled trial of an Ebola vaccine undertaken in Liberia during the 2014-15 West African outbreak.